Laboratorios Poen   Report issue

For profit Phase 4
Founded: Buenos Aires Argentina (1933)
Status: No NME R&D (1933)

Organization Overview

First Clinical Trial
2017
NCT03331770
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Laboratorios Poen

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cataract (Phase 4)

Glaucoma (Phase 4)

Glaucoma, Open-Angle (Phase 4)

Inflammation (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 8